Quantcast
NFL Trauma-Related Cognitive Issues Likely To Affect

NFL: Trauma-Related Cognitive Issues Likely To Affect One-Fourth Of All Players

Chuck Bednar for redOrbit.com - Your Universe Online Documents filed by lawyers representing the National Football League (NFL) acknowledge that at least one-fourth of players are likely to wind up suffering from dementia, Alzheimer's disease,...

Latest dementia Stories

2014-09-17 23:07:01

Fuel For Thought® coconut oil beverage helps support natural ketone production Bloomfield, CT (PRWEB) September 17, 2014 Promising new research published in the Journal of Alzheimer’s Disease (August 2014) sheds more light on the potential ability of ketones to support brain function in people with mild Alzheimer’s disease dementia. The study shows that brain hypometabolism associated with mild Alzheimer’s disease dementia may be caused by impaired glucose uptake and/or...

2014-09-16 23:05:58

Detection, at the Icahn School of Medicine at Mount Sinai, while the patient is still alive improves accuracy of diagnosis and enables estimation of prevalence and risk. New York, NY (PRWEB) September 16, 2014 An experimental positron emission tomography (PET) tracer is effective in diagnosing concussion-related brain disease while a person is still alive, according to a case study conducted at the Icahn School of Medicine at Mount Sinai, and at Molecular Neuroimaging (MNI) LLC in New...

2014-09-16 12:31:21

DementiaWise Seminar to Provide Valuable Tips to Families with Loved Ones Suffering From Dementia CHERRY HILL, N.J., Sept. 16, 2014 /PRNewswire/ -- According to the Alzheimer's Association, by the time 1 in 3 seniors pass away, they will have been afflicted with Alzheimer's disease or another form of dementia. Dementia, a term used to describe a number of cognitive diseases which impair mental functions, can be debilitating for sufferers and heartbreaking for their loved ones. On...

2014-09-16 08:29:21

INDIANAPOLIS, Sept. 16, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and AstraZeneca today announced an agreement to co-develop and commercialize AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease. The progression of Alzheimer's disease is characterized by the accumulation of amyloid plaque in the brain. BACE is an enzyme associated with the development of beta-amyloid. Inhibiting BACE...

2014-09-15 08:29:32

- Significantly Improved Agitation in 220-Patient 10-week Study - ALISO VIEJO, Calif., Sept. 15, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced positive results from its phase II clinical trial evaluating the safety and efficacy of AVP-923 for the treatment of agitation in patients with Alzheimer's disease. Treatment with AVP-923 was associated with significantly reduced agitation as measured by the primary endpoint, the agitation/aggression...

2014-09-12 12:25:19

Partnership with Brain Canada boosts innovative research to advance knowledge on neurological and mental illnesses. TORONTO, Sept. 12, 2014 /CNW/ - The Honourable Rona Ambrose, Minister of Health, along with Inez Jabalpurwala, President and CEO of Brain Canada, today announced 32 projects being funded under the Canada Brain Research Fund. The projects announced today will accelerate innovative research that will fundamentally change our understanding of nervous system...

2014-09-11 23:01:41

The Firm is representing numerous Risperdal lawsuit plaintiffs who allegedly developed gynecomastia, or male breast growth, due to their use of the antipsychotic drug. New York, New York (PRWEB) September 11, 2014 A Canadian project investigating the use of Risperdal (http://www.lawreward.com/risperdal/) and other antipsychotic medications in elderly dementia patients has reported positive outcomes when the drugs are reduced in this patient population, Bernstein Liebhard LLP reports....

2014-09-11 12:26:44

Leading researchers and industry experts discuss how to accelerate the development of new treatments and technologies to improve the lives of people with dementia and their families and caregivers OTTAWA, Sept. 11, 2014 /CNW Telbec/ - The Honourable Rona Ambrose, Canada's Minister of Health, and Mr. Philippe Zeller, Ambassador of France to Canada, today welcomed leading dementia researchers and industry experts from G7 countries to Ottawa for the Canada-France Global Dementia Legacy Event....

2014-09-10 23:09:26

Alzheimer Society of Ontario excited to participate in novel assistive-technology effort Toronto (ON) September 10, 2014 (PRWEB) September 10, 2014 The Alzheimer Society of Ontario is excited to be part of a novel effort to develop assistive technology for people with dementia. From 12-14 September, technological innovators will convene at the Toronto dementia hackathon to tackle the most pressing challenges faced by caregivers and people with dementia, and invent… on the spot…...

2014-09-10 16:26:25

The Congressman met with Dr. Dennis Gillings and a delegation from the World Dementia Council, an advocacy body created to stimulate innovation and the development of drugs, treatment and care for patients suffering from dementia WASHINGTON, Sept. 10, 2014 /PRNewswire-USNewswire/ -- Congressman Chaka Fattah (D-PA) met today on Capitol Hill with Dr. Dennis Gillings, head of the World Dementia Council, to advance their joint mission to find cures, treatments, and new drugs that will...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related